Piper Sandler analyst Yasmeen Rahimi lowered the price target on Pliant Therapeutics (NASDAQ: PLRX) to $3.00 (from $4.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE